Neurometabolic effects of ACTH on free amino compounds in opsoclonus-myoclonus syndrome

M. R. Pranzatelli, E. D. Tate, J. M. Crowley, B. Toennies, M. Creer

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

To evaluate the possible role of central free amino compounds in pediatric opsoclonus-myoclonus syndrome (OMS), 21 cerebrospinal fluid (CSF) amino compounds were measured by an amino acid analyzer or mass spectroscopy in 74 anesthetized children, 54 with OMS and 20 age-matched neurological controls. In OMS, only phosphoethanolamine was increased compared to controls; OMS severity and duration had significant converse effects on alanine and phosphoethanolamine. In contrast, corticotropin (ACTH) treatment was associated with increased alanine and phenylalanine, and decreased taurine compared to controls and untreated OMS, and increased glutamine, lysine, ornithine, and tyrosine compared to untreated OMS. Other than low taurine, these effects were not found with corticosteroid treatment, and non-steroidogenic immunotherapy had no effect. The ACTH dose-association was most apparent for alanine and phosphoethanolamine, but lysine and ornithine were also higher in the high-dose ACTH group. There were no significant disease- or treatment-associated perturbations in GABA, glycine, or other amino acids. These data suggest a unique pattern of ACTH effects on non-neurotransmitter CSF amino compounds, for the most part not shared by steroids.

Original languageEnglish (US)
Pages (from-to)164-171
Number of pages8
JournalNeuropediatrics
Volume39
Issue number3
DOIs
StatePublished - Jun 2008

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Neurometabolic effects of ACTH on free amino compounds in opsoclonus-myoclonus syndrome'. Together they form a unique fingerprint.

Cite this